custom image

Emerging Cell Therapies:
Realizing the Vision of NextGen Cell Therapeutics

January 25-27, 2021 | 10:00AM EDT | 2:00PM UTC | 4:00PM CEST*
*Program is subject to change


Cellular therapeutics are poised to be a next pillar of medicine along with small molecules and biologics. These living drugs have a unique capacity for more complex decision-making and therapeutic responses, potentially alleviating the need for chronic treatment. Next-generation cell therapies will need to adapt and respond to disease progression, essentially functioning as microscopic “physicians” capable of sensing, diagnosing, and eradicating disease via multifaceted mechanisms that are difficult to resist yet similar to our natural immune system. Advances in engineered T cell therapeutics are being FDA approved and are now transforming treatment plans for cancers that previously had few therapeutic options. While there have been unprecedented complete responses in a subset of hematological malignancies, the current therapies can show significant toxicity and on the other hand show a lack of efficacy in solid tumors. Beyond cancer, engineered cell therapies could have significant impact in the treatment of autoimmunity, metabolic disorders and in regenerative medicine. This conference will therefore cover next-generation cellular engineering approaches designed to tackle refractory diseases such as solid tumors, while also addressing the higher safety requirements for diseases beyond late-stage metastatic cancers. This conference brings together clinically minded cell therapists, synthetic biologists, genome and protein engineers, systems biologists, and immunologists; this combined expertise is essential to establish cells as a safe and effective therapeutic strategy across a range of diseases. Smart cellular therapeutics of the future must be easily customizable, have intrinsic control systems to prevent toxicity, and be able to overcome rapidly evolving mechanisms preventing disease resolution; this conference aims to address these topics by convening global experts across a range of relevant disciplines.

Pricing:

Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD

Deadlines:

Abstract Submission
for Short Talk Consideration:
December 15, 2020

ePoster Abstract Submission: January 11, 2021

Financial Aid Application: January 11, 2021

#VKSSmartCells21


Financial Aid Opportunities

Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine related fields, are eligible to apply for a FREE registration code.

Find out more about financial aid opportunities here!


Call For Abstracts

Showcase your work to global audiences on the eSymposia platform!

Submit your abstract for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program! See Abstract Deadline for Short Talk Consideration

ePoster presenters will be provided with their own dedicated page on the event website to display their work in multiple formats and interact with meeting participants. ePoster features include:

  • Abstract
  • Poster PDF for download
  • SciTalk – up to 5 minute video presentation, available on-demand
  • Live chat function to answer audience questions in real-time
  • Contact information for private follow-up discussion

To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.



Program Details



Speaking at this eSymposia


David Baker

University of Washington, USA


Christine E. Brown

Beckman Research Institute, City of Hope, USA


Dario Campana

National University of Singapore, Singapore


Yvonne Y. Chen

University of California, Los Angeles, USA


Tal Danino

Columbia University, USA


Tara L. Deans

University of Utah, USA


David Edward Gilham

Celyad, Belgium


Saar I. Gill

University of Pennsylvania, USA


Jane L. Grogan

Arsenal Biosciences, USA


Darrell J. Irvine

Massachusetts Institute of Technology, USA



More program details will be available soon.


Subscribe to receive updates to the program for this meeting.


Email address:    



Sponsors



custom image
custom image
custom image
custom image
custom image
custom image
custom image
custom image
custom image
custom image
custom image

Funding for this conference was made possible (in part) by 1R13CA246936-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.




Media In-Kind Sponsors



EMBO
JEM and JCB
Frontiers
custom image







The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






Related Keystone Symposia In-Person Meetings

Explore all cancer-related meetings on the Keystone Symposia website.

custom image
custom image
custom image






Donate to Keystone Symposia


custom image